Skip to main content
. 2026 Jun 23;8:1800552. doi: 10.3389/fdgth.2026.1800552

Table 8.

Cross database recalls for best performing models trained with different frameworks and SVD database.

Framework (Feature) task Hyperfunction Laryngitis Leukoplakia Normal Reinke’s Edema Paralysis Polyp Average
AVFAD
CaRLab 2025 (MFCCDD) /a/ – 66 – 2 52 71 49 48
(MFCCDD) inj. P/N – 66 – 13 39 44 50 42
USVAC 2025 2 (Wav2Vec) ensemble – 59 – 2 33 32 58 37
(MFCCDD) inj. P/N – 55 – 14 12 48 14 29
da Silva Moura 2024 (UnispeechSAT) phrase – 100 – 0 3 99 5 41
(MFCCDD) inj. P/N – 70 – 21 12 73 11 37
narrow (UnispeechSAT) ensemble – 86 – 0 1 51 0 28
(MFCCDD) inj. N – 50 – 32 5 48 2 27
MEEI
CaRLab 2025 (MFCCDD) /a/ 4 – 25 49 50 62 86 46
(MFCCDD) inj. P/N 7 – 100 78 0 48 64 50
USVAC 2025 2 (MFCCDD) /a/ 9 – 75 44 50 43 64 48
(Wav2Vec) inj. P/N 41 – 0 91 50 24 36 40
da Silva Moura 2024 (MFCCDD) all 3 – 75 84 50 29 86 54
(UnispeechSAT) inj. P/N 16 – 100 86 100 0 71 62
narrow (UnispeechSAT) /a/ 11 – 0 25 50 76 0 27
(UnispeechSAT) inj. P/N 64 – 0 73 0 0 36 29
VOICED
CaRLab 2025 (MFCCDD) phrase – 61 – 2 67 20 67 43
(Wav2Vec) inj. P/N – 47 – 56 0 0 33 27
USVAC 2025 2 (Wav2Vec) /a/phrase – 21 – 30 67 20 17 31
(Wav2Vec) inj. P/N – 0 – 75 0 20 0 19
da Silva Moura 2024 (UnispeechSAT) phrase – 100 – 0 0 100 0 40
(Wav2Vec) inj. P/N – 0 – 79 33 20 33 33
narrow (MFCCDD) inj. P/N – 0 – 0 0 0 83 17
(UnispeechSAT) /a/ – 0 – 54 33 80 0 33

Bold values mark the best-performing configuration.